Johnson & Johnson Says We Remain On Track For The Planned Separation Of Depuy Synthes By Mid 2027

10/13/2026
Impact: 50
Healthcare

Johnson & Johnson announced during a conference call that it remains on track for the planned separation of its DePuy Synthes business by mid-2027. This strategic move is part of the company's ongoing efforts to streamline operations and focus on its core areas. No specific financial figures or impacts on stock price were mentioned in the announcement.

AI summary, not financial advice

Share: